TI
SGNT

Trexquant Investment’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Trexquant Investment’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-74,373
Closed -$905K – 1277
2016
Q1 		$905K Buy
+74,373
New +$1.04M 0.11% 328
2015
Q3 		– Sell
-31,400
Closed -$763K – 1454
2015
Q2 		$763K Buy
+31,400
New +$752K 0.09% 448

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Trexquant Investment's SGNT Position: Q2 2016 in Review

Trexquant Investment sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 74,373 shares — an estimated $905K sold.

Trexquant Investment first reported a position in SGNT in Q2 2015 and held it in 2 quarters. The position peaked at $905K in Q1 2016. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Trexquant Investment reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Trexquant Investment sold 74,373 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $905K.
  • Trexquant Investment first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 2 quarters.
  • Trexquant Investment's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $905K in Q1 2016.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Trexquant Investment's 13F filing for Q2 2016, filed 10 Aug 2016.